The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia

被引:12
|
作者
Fan, Yingchao [1 ]
Cao, Yanan [1 ]
Bai, Xiaosong [1 ]
Zhuang, Wenfang [1 ]
机构
[1] Shidong Hosp Yangpu Dist, Dept Lab Diag, Shanghai, Peoples R China
关键词
FLT3; acute promyelocytic leukemia; 5-year OS; 5-year DFS; CR rate; meta-analysis; survival; odds ratio; ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; TRANS-RETINOIC ACID; RAS GENE-MUTATIONS; ARSENIC TRIOXIDE; RISK GROUP; THERAPY; IMPACT; INDUCTION; CONSOLIDATION;
D O I
10.1080/10245332.2017.1415717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: To explore the relationship between FLT3 (encoding Fms related tyrosine kinase 3) internal tandem duplication (ITD) mutations with the prognosis of acute promyelocytic leukemia. The PubMed database, the Cochrane Library, conference proceedings, the EMBASE databases, and references of published trials and review articles were searched. Two reviewers independently assessed the quality of the trials and extracted the data. Odd ratios (ORs) for complete remission (CR) rate after induction therapy, 5-year overall survival (OS), and 5-year disease free survival (DFS) were pooled using the STATA package. Main results: Seventeen trials involving 2252 patients were ultimately analyzed. The pooled OR showed that the FLT3 ITD mutation group had a poor prognosis in terms of CR rate (OR = 0.53, 95% confidence interval (CI), 0.30-0.95, P= 0.03), 5-year OS (OR = 0.47, 95% CI, 0.29-0.75, P= 0.002), and as 5-year DFS (OR = 0.48, 95% CI, 0.29-0.78; p= 0.003). Conclusions: The results suggested that FLT3 ITD mutations could become an indicator of poor prognosis of APL, and these patients should receive more intensive therapy according to current guidelines.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 50 条
  • [1] Acute Promyelocytic Leukemia with Atypical Karyotype and FLT3 ITD Mutation is Associated with Inferior Clinical Outcome
    Idrees, A.
    Sharma, R.
    Nguyen, L.
    Menes, M.
    Papenhausen, P.
    Zhang, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 969 - 969
  • [2] Clinical significance of FLT3/ITD and NPM1 mutation in acute myeloid leukemia (AML).
    Suzuki, Rikio
    Onizuka, Makoto
    Shimada, Masako
    Iwaki, Yasunobu
    Kawada, Hiroshi
    Ogawa, Yoshiaki
    Hotta, Tomomitsu
    Ando, Kiyoshi
    BLOOD, 2006, 108 (11) : 188B - 188B
  • [3] FLT3 Gene Mutation Profile and Prognosis in Adult Acute Myeloid Leukemia
    Azari-Yam, Aileen
    Tavakkoly-Bazzaz, Javad
    Semnani, Yousef
    Davoudi-Dehaghani, Elham
    Ghodssi-Ghassemabadi, Robabeh
    Kianfar, Soodeh
    Saadat, Ameneh
    Masoudifard, Mahboobeh
    Yaghmaie, Marjan
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Zeinali, Sirous
    CLINICAL LABORATORY, 2016, 62 (10) : 2011 - 2017
  • [4] Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia
    Song, Yu-hua
    Peng, Peng
    Qiao, Chun
    Li, Jian-yong
    Long, Qi-qiang
    Lu, Hua
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2371 - 2378
  • [5] Acute myeloid leukemia with NPM1 and FLT3 ITD mimicking acute promyelocytic leukemia
    Pepper, Michael
    Tan, Brent
    BLOOD, 2020, 136 (12) : 1467 - 1467
  • [6] ADVERSE PROGNOSTIC SIGNIFICANCE OF FLT3 MUTATIONS IN ACUTE PROMYELOCYTIC LEUKEMIA
    Mitrovic, M.
    Suvajdzic, N.
    Tosic, N.
    Bogdanovic, A.
    Djunic, I.
    Sretenovic, A.
    Vidovic, A.
    Virijevic, M.
    Colovic, N.
    Kostic, T.
    Karan-Djurasovic, T.
    Glumac, I.
    Spasovski, V.
    Pavlovic, S.
    Elezovic, I.
    Tomin, D.
    HAEMATOLOGICA, 2013, 98 : 282 - 283
  • [7] FLT3-ITD in acute promyelocytic leukemia: Clinical distinct profile but still controversial prognosis
    Molica, Matteo
    Breccia, Massimo
    LEUKEMIA RESEARCH, 2015, 39 (04) : 397 - 399
  • [8] Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia
    Li, Chenglong
    Zhu, Biao
    Chen, Jiao
    Huang, Xiaobing
    MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 89 - 94
  • [9] FLT3 AND FLT3-ITD GENE MUTATIONS AND PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Chen, L. G.
    Pei, R. Z.
    Lu, Y.
    Zhang, P. S.
    Liu, X. H.
    Du, X. H.
    Chen, D.
    Cao, J. J.
    Li, S. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06): : 1855 - 1861
  • [10] Acute Promyelocytic Leukemia with FLT3/ITD and RUNX1 Mutation Presenting As Extramedullary Soft Tissue Mass
    Mori, Shahram
    Yuan, Cai
    Ahmed, Wesam B.
    Patel, Rushang D.
    BLOOD, 2016, 128 (22)